AUD 0.07
(-4.11%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | - AUD | 0.0% |
2023 | - AUD | -100.0% |
2022 | 84.6 Thousand AUD | 0.0% |
2021 | - AUD | 0.0% |
2020 | - AUD | 0.0% |
2019 | - AUD | 0.0% |
2018 | - AUD | 0.0% |
2017 | - AUD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - AUD | 0.0% |
2024 Q4 | - AUD | 0.0% |
2024 FY | - AUD | 0.0% |
2023 FY | - AUD | -100.0% |
2023 Q2 | 38.93 Thousand AUD | 0.0% |
2023 Q4 | - AUD | 0.0% |
2022 Q4 | 84.6 Thousand AUD | 0.0% |
2022 FY | 84.6 Thousand AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2021 Q2 | - AUD | 0.0% |
2021 FY | - AUD | 0.0% |
2021 Q4 | - AUD | 0.0% |
2020 Q4 | - AUD | 0.0% |
2020 FY | - AUD | 0.0% |
2020 Q2 | 10.73 Thousand AUD | 0.0% |
2019 Q4 | - AUD | 0.0% |
2019 Q2 | - AUD | 0.0% |
2019 FY | - AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2018 FY | - AUD | 0.0% |
2018 Q2 | - AUD | 0.0% |
2017 FY | - AUD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Australian Clinical Labs Limited | 55.06 Million AUD | 100.0% |
BCAL Diagnostics Limited | 400.22 Thousand AUD | 100.0% |
Genetic Signatures Limited | - AUD | NaN% |
Genetic Technologies Limited | - AUD | NaN% |
Healius Limited | 420.8 Million AUD | 100.0% |
Imagion Biosystems Limited | 750 Thousand AUD | 100.0% |
Integral Diagnostics Limited | 219.75 Million AUD | 100.0% |
INOVIQ Ltd | - AUD | NaN% |
Microba Life Sciences Limited | - AUD | NaN% |
Monash IVF Group Limited | 59.56 Million AUD | 100.0% |
Sonic Healthcare Limited | 2.69 Billion AUD | 100.0% |